• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.

作者信息

Trigg J K, Mbwana H, Chambo O, Hills E, Watkins W, Curtis C F

机构信息

London School of Hygiene and Tropical Medicine, UK.

出版信息

Acta Trop. 1997 Feb;63(2-3):185-9. doi: 10.1016/s0001-706x(96)00617-1.

DOI:10.1016/s0001-706x(96)00617-1
PMID:9088432
Abstract
摘要

相似文献

1
Resistance to pyrimethamine/sulfadoxine in Plasmodium falciparum in 12 villages in north east Tanzania and a test of chlorproguanil/dapsone.坦桑尼亚东北部12个村庄恶性疟原虫对乙胺嘧啶/磺胺多辛的耐药性及氯胍/氨苯砜的试验
Acta Trop. 1997 Feb;63(2-3):185-9. doi: 10.1016/s0001-706x(96)00617-1.
2
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.氯胍-氨苯砜用于治疗坦桑尼亚的耐药恶性疟。
Lancet. 2001 Oct 13;358(9289):1218-23. doi: 10.1016/S0140-6736(01)06344-9.
3
Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.三种抗疟方案用于婴儿疟疾间歇性预防治疗的保护效果及安全性：一项随机、双盲、安慰剂对照试验
Lancet. 2009 Oct 31;374(9700):1521-32. doi: 10.1016/S0140-6736(09)60997-1. Epub 2009 Sep 16.
4
Chlorproguanil-dapsone: effective treatment for uncomplicated falciparum malaria.氯胍-氨苯砜：治疗非复杂性恶性疟的有效药物。
Antimicrob Agents Chemother. 1997 Oct;41(10):2261-4. doi: 10.1128/AAC.41.10.2261.
5
A trial of proguanil-dapsone in comparison with sulfadoxine-pyrimethamine for the clearance of Plasmodium falciparum infections in Tanzania.在坦桑尼亚进行的一项关于氯胍-氨苯砜与周效磺胺-乙胺嘧啶清除恶性疟原虫感染效果对比的试验。
Trans R Soc Trop Med Hyg. 2001 Jul-Aug;95(4):433-8. doi: 10.1016/s0035-9203(01)90207-x.
6
In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanil-dapsone treatment.通过乙胺嘧啶-磺胺多辛而非氯胍-氨苯砜治疗对恶性疟原虫二氢蝶酸合酶的特定基因型进行体内选择。
J Infect Dis. 1998 May;177(5):1429-33. doi: 10.1086/517831.
7
Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.磺胺多辛-乙胺嘧啶和氯胍-氨苯砜治疗恶性疟原虫疟疾失败的分子标志物
J Infect Dis. 2002 Feb 1;185(3):380-8. doi: 10.1086/338566. Epub 2002 Jan 17.
8
Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.磺胺多辛-乙胺嘧啶、氯胍-氨苯砜或氯喹用于治疗阿富汗和巴基斯坦间日疟原虫疟疾：一项随机对照试验。
JAMA. 2007 May 23;297(20):2201-9. doi: 10.1001/jama.297.20.2201.
9
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.氯胍-氨苯砜与磺胺多辛-乙胺嘧啶用于肯尼亚和马拉维单纯性恶性疟连续发作的疗效比较：一项随机临床试验
Lancet. 2002 Oct 12;360(9340):1136-43. doi: 10.1016/s0140-6736(02)11198-6.
10
Chlorproguanil-dapsone for malaria in Africa.氯胍-氨苯砜用于非洲疟疾治疗
Lancet. 2004 Jun 5;363(9424):1838-9. doi: 10.1016/S0140-6736(04)16390-3.

引用本文的文献

1
Inference and dynamic simulation of malaria using a simple climate-driven entomological model of malaria transmission.利用简单的疟疾传播气候驱动虫媒模型进行疟疾的推断和动态模拟。
PLoS Comput Biol. 2022 Jun 9;18(6):e1010161. doi: 10.1371/journal.pcbi.1010161. eCollection 2022 Jun.
2
Genetic diversity and signatures of selection of drug resistance in Plasmodium populations from both human and mosquito hosts in continental Equatorial Guinea.赤道几内亚大陆人体和蚊媒疟原虫种群的遗传多样性及耐药性选择特征。
Malar J. 2013 Mar 27;12:114. doi: 10.1186/1475-2875-12-114.
3
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
东非坦桑尼亚东南部恶性疟原虫二氢叶酸还原酶对氨苯砜耐药的演变：比较单纯氨苯砜与氨苯砜-青蒿琥酯联合用药下的选择压力。
Malar J. 2011 Oct 26;10:317. doi: 10.1186/1475-2875-10-317.
4
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.抗疟药物治疗中的药物覆盖范围及其对耐药进化的影响——来自使用磺胺多辛/乙胺嘧啶的证据。
Malar J. 2010 Jul 5;9:190. doi: 10.1186/1475-2875-9-190.
5
Using the social entrepreneurship approach to generate innovative and sustainable malaria diagnosis interventions in Tanzania: a case study.利用社会创业方法在坦桑尼亚生成创新性和可持续的疟疾诊断干预措施：案例研究。
Malar J. 2010 Feb 3;9:42. doi: 10.1186/1475-2875-9-42.
6
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.非洲恶性疟原虫疟疾中耐药二氢蝶酸合酶（DHPS）的多重起源与区域传播
PLoS Med. 2009 Apr 14;6(4):e1000055. doi: 10.1371/journal.pmed.1000055.
7
Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.扁桃斑鸠菊叶水提取物增强氯喹对感染氯喹抗性和敏感伯氏疟原虫菌株小鼠的抗疟效果。
Afr Health Sci. 2008 Mar;8(1):25-35.
8
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.坦桑尼亚北部恶性疟原虫对周效磺胺/乙胺嘧啶的高抗性以及第581位密码子二氢蝶酸合酶（DHPS）抗性突变的出现。
PLoS One. 2009;4(2):e4569. doi: 10.1371/journal.pone.0004569. Epub 2009 Feb 24.
9
Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.赞比亚农村地区马查恶性疟原虫抗叶酸药物耐药性突变情况不断升级
Malar J. 2008 May 21;7:87. doi: 10.1186/1475-2875-7-87.
10
Chlorproguanil-dapsone for treating uncomplicated malaria.氯胍-氨苯砜治疗非复杂性疟疾。
Cochrane Database Syst Rev. 2004 Oct 18;2004(4):CD004387. doi: 10.1002/14651858.CD004387.pub2.